{"id":"https://openalex.org/W99290919","doi":"https://doi.org/10.1097/ppo.0b013e318156fe69","title":"Renal Cell Cancer","display_name":"Renal Cell Cancer","publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W99290919","doi":"https://doi.org/10.1097/ppo.0b013e318156fe69","mag":"99290919","pmid":"https://pubmed.ncbi.nlm.nih.gov/17921725"},"language":"en","primary_location":{"id":"doi:10.1097/ppo.0b013e318156fe69","doi":"https://doi.org/10.1097/ppo.0b013e318156fe69","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ppo.0b013e318156fe69","pdf_url":null,"source":{"id":"https://openalex.org/S4210176243","display_name":"The Cancer Journal","issn_l":"1528-9117","issn":["1528-9117","1540-336X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Cancer Journal","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102785664","display_name":"Thomas E. Hutson","orcid":"https://orcid.org/0000-0002-4529-4212","observed_orcids":["https://orcid.org/0000-0002-4529-4212"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas E. Hutson","raw_affiliation_strings":["Genitourinary Oncology Program, Texas Oncology, PA, Baylor Sammons Cancer Center, and US Oncology Research Network, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genitourinary Oncology Program, Texas Oncology, PA, Baylor Sammons Cancer Center, and US Oncology Research Network, Dallas, Texas, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050649350","display_name":"Robert A. Figlin","orcid":"https://orcid.org/0000-0002-6323-6075","observed_orcids":["https://orcid.org/0000-0002-6323-6075"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Figlin","raw_affiliation_strings":["From the Genitourinary Oncology Program, Texas Oncology, PA, Baylor Sammons Cancer Center, and US Oncology Research Network, Dallas, Texas","and Division of Medical Oncology and Experimental Therapeutics, City of Hope National Medical Center and Beckman Research Institute Duarte, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Genitourinary Oncology Program, Texas Oncology, PA, Baylor Sammons Cancer Center, and US Oncology Research Network, Dallas, Texas","institution_ids":["https://openalex.org/I2800124591"]},{"raw_affiliation_string":"and Division of Medical Oncology and Experimental Therapeutics, City of Hope National Medical Center and Beckman Research Institute Duarte, California","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.21,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.19691781,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"13","issue":"5","first_page":"282","last_page":"286"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9079999923706055},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8579999804496765},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.6980000138282776},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.7990000247955322},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9599999785423279},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9729999899864197},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9670000076293945},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/interferon","display_name":"interferon","score":0.4429999887943268},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2776820818","wikidata":"https://www.wikidata.org/wiki/Q7699074","display_name":"Temsirolimus","level":5,"score":0.9337731599807739},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.8059015870094299},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.7671300172805786},{"id":"https://openalex.org/C2908861226","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib malate","level":4,"score":0.7246646285057068},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7109341025352478},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5189926028251648},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.49955224990844727},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.49395185708999634},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.449840784072876},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.4362364113330841},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4284113347530365},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4118986427783966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38784271478652954},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3809136748313904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3580952286720276},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.31126123666763306},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.25165003538131714},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19009289145469666},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17232003808021545},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.13530337810516357},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.10886082053184509},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/ppo.0b013e318156fe69","doi":"https://doi.org/10.1097/ppo.0b013e318156fe69","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ppo.0b013e318156fe69","pdf_url":null,"source":{"id":"https://openalex.org/S4210176243","display_name":"The Cancer Journal","issn_l":"1528-9117","issn":["1528-9117","1540-336X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Cancer Journal","raw_type":"journal-article"},{"id":"pmid:17921725","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17921725","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer journal (Sudbury, Mass.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W81857156","https://openalex.org/W83302227","https://openalex.org/W638135163","https://openalex.org/W1965734230","https://openalex.org/W1998400563","https://openalex.org/W1999966467","https://openalex.org/W2014404252","https://openalex.org/W2018348203","https://openalex.org/W2046507292","https://openalex.org/W2050026229","https://openalex.org/W2099259685","https://openalex.org/W2105677187","https://openalex.org/W2105984177","https://openalex.org/W2116177733","https://openalex.org/W2120129511","https://openalex.org/W2140765540","https://openalex.org/W2149456801","https://openalex.org/W2153867442","https://openalex.org/W2156408558","https://openalex.org/W2166271687","https://openalex.org/W2217288524","https://openalex.org/W2225151298","https://openalex.org/W2253554231","https://openalex.org/W2256356298","https://openalex.org/W2301603902","https://openalex.org/W2325164446","https://openalex.org/W2342254197","https://openalex.org/W2782677799","https://openalex.org/W3009736595","https://openalex.org/W3009848639","https://openalex.org/W3010916979"],"related_works":["https://openalex.org/W2119535120","https://openalex.org/W50109002","https://openalex.org/W2168878075","https://openalex.org/W1971397741","https://openalex.org/W2074027443","https://openalex.org/W2315549364","https://openalex.org/W2061910516","https://openalex.org/W2074978517","https://openalex.org/W2075603542","https://openalex.org/W2333257131"],"abstract_inverted_index":{"Metastatic":[0],"renal":[1,19,110,132],"cell":[2,111],"cancer":[3,20,133],"has":[4,21],"traditionally":[5],"been":[6,57],"treated":[7],"with":[8],"interferon":[9],"and":[10,41,45,67,115],"interleukin-2.":[11],"An":[12],"improved":[13,71],"understanding":[14],"of":[15,18,33,49,90,108,124,129,140],"the":[16,30,46,88,106,122,138],"biology":[17],"engendered":[22],"novel":[23,142],"targeted":[24],"therapeutic":[25,60],"agents":[26,79],"that":[27],"have":[28,56,70,80],"altered":[29],"natural":[31],"history":[32],"this":[34],"disease.":[35],"The":[36,127],"vascular":[37],"endothelial":[38],"growth":[39],"factor":[40],"its":[42],"related":[43],"receptor":[44],"mammalian":[47],"target":[48],"rapamycin":[50],"signal":[51],"transduction":[52],"pathway":[53],"in":[54,74,84],"particular":[55],"utilized":[58],"as":[59,97],"targets.":[61],"Sunitinib":[62],"malate,":[63],"sorafenib":[64],"tosylate,":[65],"temsirolimus,":[66],"bevacizumab/interferon":[68],"alfa":[69],"clinical":[72,117],"outcomes":[73],"randomized":[75],"trials.":[76],"Other":[77],"antiangiogenic":[78],"also":[81],"demonstrated":[82],"activity":[83],"early":[85],"studies.":[86],"Given":[87],"availability":[89],"multiple":[91],"treatment":[92],"options,":[93],"several":[94],"questions":[95],"emerge":[96],"to":[98,100,137],"how":[99],"integrate":[101],"these":[102,125,141],"new":[103],"therapies":[104],"into":[105],"management":[107],"metastatic":[109],"cancer.":[112],"Recently":[113],"reported":[114],"planned":[116],"trials":[118],"will":[119],"help":[120],"clarify":[121],"role":[123],"agents.":[126,143],"future":[128],"therapy":[130],"for":[131],"appears":[134],"promising":[135],"owing":[136],"efficacy":[139]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}